WorldMarketStudy announces it Will Carry GlobalData’s Periodontal Disease – Drug Pipeline Analysis and Market Forecasts to 2016 June reports in its store.

Browse complete report at http://www.worldmarketstudy.com/market-report/periodontal-disease-drug-pipeline-analysis-market-forecasts-2016-706.html

GlobalData, the industry analysis specialist’s new report, “Periodontal disease – Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global periodontal disease market. The report identifies the key trends shaping and driving the global periodontal disease market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global periodontal disease sector.

The global periodontal disease market was valued at $1,248m in 2009 and is characterized by efficacious dental procedures such as scaling, root planing and surgery. The periodontal therapeutics market comprises Local Applied Antibodies (LAAs) and systemic applied antibodies. The influx of new drugs and the increase in the uptake of LAAs will the drive the market in the forecast period. The various phases of the developmental pipeline contain 19 molecules. Of these, only five are in Phase III and the rest are in the early stages of development. The pipeline consists of no new antibiotics. The combinations of the tetracylines are expected to improve the efficacy of the treatment. However, the drug is similar in nature to doxycyclines. The entry of cost effective drugs in the forecast period is expected to aid the market growth.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

Scope

The scope of the report includes:

  • Annualized global periodontal disease market revenues data from 2001 to 2009, forecast for seven years to 2016.
  • Geographies covered in this report are the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France, and Japan.
  • Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. The key classes of mechanism of action include tetracycline antibiotics, osteoblast stimulators and anti-inflammatories, H+/K+ ATPase inhibitors; cell wall synthesis inhibitors.
  • Analysis of the current and future market competition in the global periodontal disease market. The key market players covered are Kaken Pharmaceutical, Fibrocell Science, Inc., and Combinatorx, Inc.
  • Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
  • Key topics covered include a strategic competitor assessment, market characterization, unmet needs and implications for the future periodontal disease market.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

  • Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global periodontal disease market.
  • Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global periodontal disease market in future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
  • What’s the next big thing in the global periodontal disease market landscape? – Identify, understand and capitalize

1 Table of contents
1.1 List of Tables
1.2 List of Figures

2 Global Periodontal Disease: Market Characterization
2.1 Overview
2.1.1 Treatment Options
2.2 Periodontal Disease Market Size
2.3 Periodontal Disease Market Forecast and CAGR
2.4 Drivers and Barriers for the Periodontal Disease Market
2.4.1 Drivers for the Periodontal Disease Market
2.4.2 Barriers for the Periodontal Disease Market
2.5 Opportunity and Unmet Need
2.6 Key Takeaway

3 Global Periodontal Disease Market: Competitive Assessment
3.1 Overview
3.2 Strategic Competitor Assessment
3.3 Product Profile for the Major Marketed Products in the Periodontal Disease Market
3.3.1 Periostat (Doxycycline Hyclate)
3.3.2 Arestin (minocycline hydrochloride microspheres)
3.3.3 Periochip (chlorhexidine gluconate)
3.3.4 Atridox (doxycycline hyclate 10%)
3.4 Key Takeaway

4 Global Periodontal Disease Market: Pipeline Assessment
4.1 Overview
4.2 Strategic Pipeline Assessment
4.3 Periodontal Disease Market – Promising Drugs under Clinical Development
4.4 Molecule Profile for Promising Drugs under Clinical Development
4.4.1 Minocycline HCl
4.4.2 Trafermin (bFGF: Basic fibroblast growth factor)
4.5 Periodontal Disease Market – Clinical Pipeline by Mechanism of Action
4.5.1 Periodontal Disease – Phase III Clinical Pipeline
4.5.2 Periodontal Disease – Phase II Clinical Pipeline
4.5.3 Periodontal Disease – Phase I Clinical Pipeline
4.5.4 Periodontal Disease- Preclinical Pipeline
4.6 Key Takeaway

5 Global Periodontal Disease Market: Implications for Future Market Competition

6 Global Periodontal Disease Syndrome Market: Future Players
6.1 Introduction
6.2 Fibrocell Sciences, Inc
6.2.1 Company Overview
6.2.2 Business description
6.3 Orapharma
6.3.1 Company Overview
6.3.2 Business Description
6.4 Tolmar Inc
6.4.1 Company Overview
6.4.2 Business Description
6.5 Kaken Pharmaceutical
6.5.1 Overview
6.5.2 Business Description
6.6 Eli Lilly & Company
6.6.1 Company Overview
6.6.2 Business Description

7 Periodontal disease Market: Appendix
7.1 Definitions
7.2 Acronyms
7.3 Research Methodology
7.3.1 Coverage
7.3.2 Secondary Research
7.3.3 Forecasting
7.3.4 Primary Research
7.3.5 Expert Panels
7.4 Contact Us
7.5 Disclaimer
7.6 Sources

1.1 List of Tables
Table 1: Various Types of Medications Employed in Treating the Periodontal Disease 6
Table 2: Periodontal Disease, Global, Historical Revenue ($m), 2001-2009 7
Table 3: Periodontal Disease, Global, Forecasted Reveune ($m), 2009-2016 8
Table 4: Major Marketed Products Comparison in Periodontal Disease Market, 2010 16
Table 5: Periodontal Disease – Most Promising Drugs Under Clinical Development, 2010 20
Table 6: Periodontal Disease – Phase III Clinical Pipeline, 2010 22
Table 7 Periodontal Disease- Phase II Clinical Pipeline, 2010 22
Table 8 Periodontal Disease – Phase I Clinical Pipeline, 2010 23
Table 9: Periodontal Disease – Preclinical Pipeline, 2010 23
Table 10: Fibrocell Sciences, Inc – Periodontal disease Pipeline Product Portfolio, 2010 26
Table 11: Genzyme Corporation – Periodontal Disease Pipeline Product Portfolio, 2010 26
Table 12: Tolmar, Inc – Periodontal Disease Pipeline Product Portfolio, 2010 27
Table 13: Kaken Pharmaceutical – Periodontal Pipeline Product Portfolio, 2010 28
Table 14: Eli Lilly – Periodontal Disease Pipeline Product Portfolio, 2010 29

1.2 List of Figures
Figure 1: Periodontal Disease, Global, Historical Revenue ($m), 2001-2009
Figure 2: Periodontal Disease, Global, Forecasted Revenue ($m), 2009-2016
Figure 3: Opportunity and Unmet Need in the Periodontal Disease Market, 2010
Figure 4: Strategic Competitor Assessment, 2010
Figure 5: Pipeline Products by Phase of Development, 2009
Figure 6: Technology Trends Analytics Frame Work, 2010
Figure 7: Technology Trends Analytics Frame Work – Description, 2010
Figure 8: Periodontal Disease Market – Clinical Pipeline by Mechanism of Action, 2010
Figure 9: Periodontal Disease Market – Clinical Pipeline by Phase of Development, 2010
Figure 10: Implications for Future Market Competition in the Periodontal Disease Market, 2010
Figure 11: Periodontal Disease Market – Clinical Pipeline by Company, 2010
Figure 12: GlobalData Methodology, 2010
Figure 13: GlobalData Market Forecasting Model, 2010

View All Pharmaceuticals Market Reports http://www.worldmarketstudy.com/Pharmaceuticals-market-research-4.html

About WorldMarketStudy
In these days of cut-throat market competition, sole reliance on instincts is a dangerous proposition for any business person. Successful business can only be built on the solid background of well-researched information and knowledge based decisions.

And to aid these vital decisions, we at WorldMarketStudy offer you a one point solution for all your market research requirements. We have compiled a huge and constantly updated repository of more than 200,000 market search reports collected from over 650 research reports publishers. Browse all reports at http://www.worldmarketstudy.com/

Contact
Jessica Thomas
WorldMarketStudy
+91-9881144324
http://www.worldmarketstudy.com/
http://worldmarketstudy.wordpress.com/
http://worldmarketstudy.blogspot.com/